Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr class="thead"><td class="align_left">PharmMapper server</td></tr><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td class="align_left">Ptgs1, Kcnc2, F10, Ptgs2, Diap1, Daf-2, Pik3cg, Mfn1, Ace, Cox17, Arnt, Prkca</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Targets of DA validated by PharmMapper server.</div>

Oxidative Medicine and Cellular Longevity

tab2

Table 2

Table 2: Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production 

Table 2 | Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production 